Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Coverage validation survey of preventive chemotherapy for schistosomiasis in interruption of transmission districts of Ethiopia, 2025

Churko C, Kassahun A, Zerdo Z, et al. Infectious diseases of poverty. 2026; 15 (1) : 1 - 11.
Download PDF
Publication

The Role of Veterinarians in One Health Implementation: Bridging Animal, Human and Environmental Health

Pal M, Zende R, Rebuma T, et al. Science and Education Publishing Co., Ltd.. American Journal of Public Health Research. 2026; 14 (2) : 18-24.
Download PDF
Publication

Knowledge to action: assessing the impact of schistosomiasis education on community knowledge, attitudes and practices in Nelson Mandela Bay, South Africa

Campbell P, Adams J, Thwala M, et al. Infectious diseases (London, England). 2026;
Download PDF
Publication

New technologies for identification and surveillance of Chagas disease vectors

Gurgel-Gonçalves R, Julião G, Ferreira R, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2026;
Download PDF
Publication

Evaluation of social stigma and interventions for stigma reduction in Hansen’s disease: a prospective, observational study

Chaudhary AR, Chaudhary A, Bhardwaj G, et al. Lepra. Leprosy Review. 2026; 97 (1) : 1 - 11.
Download PDF
Publication

Establishing tropical medicine as a recognized medical specialty or strengthening its training within infectious diseases residency programs in Colombia: an urgent need

Silva-Ramos C, Álvarez-Moreno C, Rodriguez-Morales A, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2026;
Download PDF
Publication

Asymptomatic lymphatic filariasis in an elderly patient from Bako, Sarawak: A case report and public health implications

Ngui R, Johnny P, Chai P, et al. Tropical biomedicine. 2026; 43 (1) : 22-25.
Download PDF
Publication

One Health assessment of fascioliasis and schistosomiasis in humans, livestock, and snail vectors in peri-urban Rwanda

Ntivuguruzwa J, Ntampaka P, Twagirayezu E, et al. Veterinary world. 2026; 19 (3) : 1368-1386.
Download PDF
Publication

Parasitic Infections and Associated Cognitive Outcome Among School-Aged Children in Africa: A Systematic Review

Adu A, Simpong D, Donkor D, et al. Brain and behavior. 2026; 16 (4) : 1 - 44.
Download PDF
Publication

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit

Hendrickx S, Ilbeigi K, Thoré E, et al. The Journal of antimicrobial chemotherapy. 2026; 81 (4) : 1 - 14.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD